Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

Ambrx, China Everbright, Hopu Investment Management, Shanghai Fosun Pharmaceutical, WuXi PharmaTech deal

May 25, 2015 7:00 AM UTC

China Everbright’s health care fund, Fosun, Hopu and WuXi will acquire Ambrx for an undisclosed amount. The consortium of buyers expects the transaction to close this quarter but did not respond to inquiries for additional details in time for publication. Ambrx declined to provide details. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article